Latest Karmanos Cancer Institute Stories
Abstract # 3179 SAN DIEGO, Oct.
2010 Komen Detroit Race for the CureÂ® Accomplishments DETROIT, Sept. 23 /PRNewswire-USNewswire/ -- Susan G.
DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center in Detroit was recently selected to be one of 50 sites in the United States to offer the new U.S.
CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties.
Student-Led Venture Fund Participates in $8 Million Series A Round of Financing led by Co-Investor Arboretum Ventures ANN ARBOR, Mich., June 3 /PRNewswire/ -- The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H.
DETROIT, June 2 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in cooperation with Blue Cross Blue Shield of Michigan and the U.S.
DETROIT, May 5 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute recently received a $2.5 million charitable donation from Franklin, Michigan resident Joseph Dresner to construct the Joseph Dresner Family Bone Marrow Transplant and Hematologic Malignancies Center at its main campus in Detroit. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) According to Karmanos President and Chief Executive Officer Gerold Bepler, M.D., Ph.D., Dresner has generously...
DETROIT, April 27 /PRNewswire-USNewswire/ -- Guests attending the Barbara Ann Karmanos Cancer Institute's 28th Annual Dinner Gala on Saturday, May 8, at the Rock Financial Showplace, will be dazzled by a stunning fashion show designed by creative icon Linda Dresner.
WASHINGTON, April 19 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research's 101st Annual Meeting 2010 that shows when genistein, a component of soy, is paired with the FDA-approved drug oxaliplatin, pancreatic cancer cells become more sensitive to chemotherapy. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) The title of the poster presentation is, "Genistein...
- totally perplexed and mixed up.